Ospedale Papa Giovanni XXIII
In research, Ospedale Papa Giovanni XXIII stands highest in Medicine (#1,209 of 10,443 worldwide) and Health Sciences (#1,675 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cardiology and Cardiovascular Medicine — Cardiology and Cardiovascular Medicine is 8.3× its share of world research.
- World rank, 2022–2025
- #5,479 of 28,054 · #6,313 all time
- Rank in Italy
- #156 of 618
- Research works
- 1.6k ▲ 31% vs 2013–17
- Citations
- 37k 22.7 per fractional work
- Top-10% rate
- 18.5% record average 16.5%
- Open access
- 54% world 28%
What is Ospedale Papa Giovanni XXIII known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,209 of 10,443 | 19.6% | 367 | #1286 | |
| Health SciencesDomain | #1,675 of 11,982 | 19.6% | 377 | #1668 |
Each strip is that field’s whole ranked pool, with the notch where Ospedale Papa Giovanni XXIII sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Ospedale Papa Giovanni XXIII specialise in?
Where its research is concentrated relative to its size: Cardiology and Cardiovascular Medicine takes 8.3× the share of its output that it takes of world research.
- Cardiology and Cardiovascular MedicineSubfield · 41.4 works8.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Immunology and Microbiology 2.1×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Nursing 1.0×
- Veterinary 0.8×
- Neuroscience 0.6×
- Health Professions 0.6×
- Arts and Humanities 0.5×
- Psychology 0.4×
- Economics, Econometrics and Finance 0.2×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Dentistry 0.2×
- Physics and Astronomy 0.2×
- Computer Science 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Decision Sciences 0.1×
- Chemical Engineering 0.1×
- Earth and Planetary Sciences 0.1×
- Chemistry 0.1×
- Materials Science 0.0×
- Mathematics 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Ospedale Papa Giovanni XXIII?
Ranked on the composite score, Roberto Labianca, Mario Mandalà and Carlo Tondini lead among researchers whose main affiliation is Ospedale Papa Giovanni XXIII.
- 1 Roberto Labianca Italy · #7,018 worldwide 941 citations · 105 works
- 2 Mario Mandalà Italy · #28,025 worldwide 558 citations · 77 works
- 3 Carlo Tondini Italy · #28,819 worldwide 501 citations · 50 works
- 4 Giulio Guagliumi Italy · #59,975 worldwide 452 citations · 60 works
- 5 Michele Senni Italy · #77,159 worldwide 395 citations · 77 works
- 6 Alessandro Rambaldi Italy · #85,106 worldwide 698 citations · 195 works
- 7 Anna Falanga Italy · #101,929 worldwide 315 citations · 79 works
- 8 Michele Pisano Italy · #182,670 worldwide 151 citations · 20 works
- 9 Stefania Mosconi Italy · #198,648 worldwide 209 citations · 18 works
- 10 Umberto Mariani Italy · #281,696 worldwide 39 citations · 22 works
Which keywords describe research at Ospedale Papa Giovanni XXIII?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Heart Failure, Treatment, Management, Prognostic Factors, Echocardiography and Guidelines.
- Liver Cirrhosis
- Minimal Residual Disease
- Antiretroviral Therapy
- Donor Risk Index
- ACE2 Receptor
- Myocardial Infarction
- Cardiovascular Risk
- Graft Survival
- Mortality
- Lymphoma
- Immunosuppressive Therapy
- Metabolic Syndrome
- Thrombosis
- Risk Factors
- Immune Response
- Immunotherapy
- Cardiovascular Disease
- Management
- Heart Failure
- Diagnosis
- Epidemiology
- Treatment
- Inflammation
- Prognostic Factors
- Guidelines
- Echocardiography
- Liver Transplantation
- Genetic Mutations
- Clinical Practice Guidelines
- Pathophysiology
- SARS-CoV-2
- Rituximab
- Prognosis
- Renal Function
- Hepatocellular Carcinoma
- Coagulopathy
- Biliary Complications
- Ischemia-Reperfusion Injury
- Hematopoietic Stem Cells
- Hepatic Encephalopathy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology62▲ 3.3×100 topics
- Diagnosis34▲ 7.6×35 topics
- Treatment29▲ 5.1×37 topics
- Heart Failure27▲ 13×13 topics
- Inflammation20▲ 2.1×60 topics
- Management20▲ 5.4×27 topics
- Prognostic Factors17▲ 8.1×14 topics
- Cardiovascular Disease16▲ 3.1×28 topics
- Guidelines15▲ 6.7×11 topics
- Immunotherapy15▲ 4.4×16 topics
- Echocardiography14▲ 11×8 topics
- Immune Response14▲ 5.2×15 topics
- Liver Transplantation13▲ 22×5 topics
- Risk Factors12▲ 2.4×23 topics
- Genetic Mutations12▲ 5.9×22 topics
- Thrombosis12▲ 9.2×6 topics
- Clinical Practice Guidelines12▲ 4.7×14 topics
- Metabolic Syndrome12▲ 3.1×19 topics
- Pathophysiology12▲ 8.0×7 topics
- Immunosuppressive Therapy10▲ 12×8 topics
- SARS-CoV-210▲ 6.7×6 topics
- Lymphoma10▲ 13×4 topics
- Rituximab10▲ 14×4 topics
- Mortality10▲ 3.6×12 topics
- Prognosis10▲ 6.1×9 topics
- Graft Survival9▲ 24×3 topics
- Renal Function8▲ 19×4 topics
- Cardiovascular Risk8▲ 5.6×7 topics
- Hepatocellular Carcinoma8▲ 8.0×3 topics
- Myocardial Infarction8▲ 7.1×7 topics
- Coagulopathy8▲ 21×2 topics
- ACE2 Receptor8▲ 6.5×3 topics
- Biliary Complications8▲ 38×1 topic
- Donor Risk Index8▲ 38×1 topic
- Ischemia-Reperfusion Injury8▲ 25×2 topics
- Antiretroviral Therapy7▲ 9.1×6 topics
- Hematopoietic Stem Cells7▲ 17×3 topics
- Minimal Residual Disease7▲ 22×2 topics
- Hepatic Encephalopathy7▲ 27×1 topic
- Liver Cirrhosis7▲ 27×1 topic
Which research topics does Ospedale Papa Giovanni XXIII publish most on?
By volume in 2022–2025: Organ Transplantation Techniques and Outcomes, Liver Disease and Transplantation, Heart Failure Treatment and Management and Cardiovascular Function and Risk Factors.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Organ Transplantation Techniques and Outcomes Surgery 8 works
- 2 Liver Disease and Transplantation Hepatology 7 works
- 3 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 6 works
- 4 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 5 works
- 5 COVID-19 Clinical Research Studies Infectious Diseases 5 works
- 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 5 works
- 7 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 5 works
- 8 Acute Myeloid Leukemia Research Hematology 5 works
- 9 CAR-T cell therapy research Oncology 5 works
- 10 Liver Disease Diagnosis and Treatment Epidemiology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ospedale Papa Giovanni XXIII's research output changed?
Output in 2018–2022 was 31% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bergamo
- University of Bergamo
- Humanitas Gavazzeni
- Centro Studi GISED
- Istituto Sperimentale Modelli E Strutture
- HeidelbergCement (Italy)
- Humanitas Castelli
- Ev-K2-Cnr
- Pedrini (Italy)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.